AMUK Healthy Living Blog

Apr
03

Candida drug resistance

Author : Dr. Apelles Econs

Daily Telegraph - September 2011: Annual Conference of Microbiologists

Candida albicans has now become the second most common, drug-resistant infection amongst hospitalised patients, after MRSA and on same incidence with clostridium difficult. 

Systemic candidiasis now carries 50% mortality rate, in hospitalised patients and those treated for cancer or HIV. Dr. Carol Munro stated that candida seems to have evolved to more resistant strains. Click here to read more

Dr Econs’ comment: Candida and some other fungi, are often present in the human intestine and generally thought to be a harmless finding there. However, in its aggressive form, it is known to produce 92 myco-toxins, which have the capacity to migrate and cause infections in parts of the body, away from the bowel.

The array of symptoms caused by fungal overgrowth in the intestine (not always candida) vary considerably. An otherwise "healthy" person may experience mild or intermittent symptoms such as bloating or tiredness. The usual laboratory tests frequently fail to identify it, with the result that the medical profession remains unconvinced about its role in human health, until it is too late: Candida is an extremely common post-mortem finding, associated with treatments for cancer or HIV.

Some years ago I sent to hospital an 81 year old patient, whom I had previously treated for fungal problems but sadly, she died of encephalitis; this was subsequently confirmed as being caused by candida. This was the world’s first reported case of candida crossing the blood-brain barrier.

And yet, today it is possible to confirm fungal overgrowth of the intestine, with some simple laboratory tests.

It is also encouraging that a small, but increasing, number of GP’s are prepared to prescribe anti-fungals, in spite of the absence of formal guidelines.

Read more about Candida

Blog

The Blogs